S&P 500 Technology Sector SEC Filings — October 26, 2026

Board authorized an additional repurchase of up to $2.5B of common stock on 2026-10-23 with no expiration date, signaling capital return confidence alongside quarterly results furnished the same day

Quarter-ended 2026-09-30 results were furnished under Item 2.02 but the filing discloses no revenue, EPS, or YoY/QoQ figures; the performance read depends on Exhibits 99.01 and 99.02

Accelerated share purchase agreement to take Besi stake to ~20% of outstanding common stock, a strategic move into a leading semiconductor equipment peer with no disclosed purchase price

CEO Archer Timothy sold 31,400 shares at $227.02 (~$7.13M) and retains 1,075,966 shares after exercising options at $30.03, a sale executed under a Rule 10b5-1 plan

Option exercise and sale cycle of 31,400 shares each (~$943K exercise cost vs ~$7.13M proceeds) indicates monetization of in-the-money awards rather than an open-market signal of reduced conviction

Besi share delivery is conditional on HSR Act waiting-period expiration or termination; regulatory delay or a second request could defer the 20% stake

No purchase price is disclosed in the 8-K, limiting investors' ability to assess accretion, dilution, or premium paid

The 8-K omits the quarter's revenue and earnings figures, so the buyback is not yet verifiable against operating performance

CEO sold ~$7.13M in a single disclosed transaction; although pre-planned under 10b5-1, it adds to the negative insider-sentiment tally in semiconductor equipment

Repurchase authorization may be modified, suspended, or terminated at any time; reliance on buybacks to support per-share metrics carries execution risk

Up to $2.5B additional repurchase authorization with flexible execution (open market, ASR, block trades, 10b5-1) supports EPS accretion and near-term demand for shares

Exhibits 99.01 and 99.02 contain the full quarterly results and CFO commentary; a reading of those numbers could reveal whether the buyback reflects strength

Approximately 20% ownership of Besi positions Applied to capture semiconductor packaging and process-technology exposure through a strategic stake, a potential route to deeper integration

Insider sale at $227.02 offers a reference price point; investors can compare against current trading and the company's guidance to judge whether the sale reflects valuation or only planned liquidity

Cadence's new $2.5B repurchase authorization signals continued use of buybacks to return excess cash in electronic design automation, a theme to track across peers for signs of sustained capital return

Applied Materials' move toward ~20% of Besi and Lam Research's insider monetization both reflect active positioning across semiconductor equipment, with strategic stakes and equity-linked compensation playing a larger role

The Lam Research sale was executed under a Rule 10b5-1 plan, consistent with pre-scheduled executive liquidity rather than discretionary timing, which tempers the signal value of the sale

Review Exhibits 99.01 and 99.02 for quarterly revenue, EPS, and guidance; filed 2026-10-26

Monitor pace of repurchases under the $2.5B authorization, approved 2026-10-23, for signals of acceleration or ASR use

Track expiration or termination of the HSR Act waiting period, which gates delivery of Besi shares; filing dated 2026-10-26

Watch for the purchase price and final ownership confirmation once shares are delivered

Monitor whether CEO Archer Timothy continues scheduled 10b5-1 sales of 31,400-share tranches following the 2026-10-26 transaction